The Clorox Company (CLX)
| Market Cap | 13.26B +3.8% |
| Revenue (ttm) | 7.20B +6.3% |
| Net Income | 677.00M -14.4% |
| EPS | 5.56 -13.0% |
| Shares Out | 121.15M |
| PE Ratio | 19.70 |
| Forward PE | 19.04 |
| Dividend | $5.00 (4.57%) |
| Ex-Dividend Date | Oct 28, 2026 |
| Volume | 3,226,017 |
| Open | 109.05 |
| Previous Close | 108.20 |
| Day's Range | 108.05 - 110.31 |
| 52-Week Range | 79.12 - 128.90 |
| Beta | 0.58 |
| Analysts | Hold |
| Price Target | 97.00 (-11.38%) |
| Earnings Date | Nov 2, 2026 |
About CLX
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorind... [Read more]
Financial Performance
In fiscal year 2026, The Clorox Company's revenue was $6.72 billion, a decrease of -5.41% compared to the previous year's $7.10 billion. Earnings were $587.00 million, a decrease of -27.53%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for CLX stock is "Hold." The 12-month stock price target is $97.0, which is a decrease of -11.38% from the latest price.
News
Clorox takeover rumor highlighted in Betaville blog
A post in Ben Harrington’s deal-focused Betaville blog discusses takeover rumors about Clorox (CLX), contacts tell The Fly.
Clorox price target raised to $94 from $87 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Clorox (CLX) to $94 from $87 and keeps an Equal Weight rating on the shares.
Clorox price target raised to $96 from $91 at UBS
UBS analyst Peter Grom raised the firm’s price target on Clorox (CLX) to $96 from $91 and keeps a Neutral rating on the shares. Clorox’s quarter was a good start,…
Clorox price target raised to $86 from $83 at JPMorgan
JPMorgan raised the firm’s price target on Clorox (CLX) to $86 from $83 and keeps an Underweight rating on the shares.
Clorox price target lowered to $96 from $100 at BofA
BofA lowered the firm’s price target on Clorox (CLX) to $96 from $100 and keeps a Neutral rating on the shares. Costs will pressure gross margin in fiscal Q2 and…
Clorox price target raised to $90 from $85 at Wells Fargo
Wells Fargo raised the firm’s price target on Clorox (CLX) to $90 from $85 and keeps an Equal Weight rating on the shares. The firm continues to see EPS within…
The Clorox Company Earnings Call Transcript: Q1 2027
FY27 organic sales guidance is 3.5%-4.5%, with ERP effects contributing ~3.5 points; excluding ERP, growth is flat to +1%. Inflation is forecast at $240 million, while H2 margin recovery relies mainly on productivity, savings and RGM.
The Clorox Company Prepared remarks: Q1 2027
The Clorox Company filed a regulatory document on November 2, 2026 disclosing important business information.
The Clorox Company Earnings release: Q1 2027
The Clorox Company released its Q1 2027 earnings on November 2, 2026, summarizing the period's financial results.
The Clorox Company Quarterly report: Q1 2027
The Clorox Company has published its Q1 2027 quarterly earnings report on November 2, 2026.
Clorox Posts Higher Revenue, Profit; Trims Outlook on Higher Costs
The maker of cleaning products and other household goods said it now expects full-year adjusted earnings per share at the lower end of its guidance range of $5.70 to $6.
Clorox Reports Q1 Fiscal Year 2027 Results, Updates Outlook
OAKLAND, Calif., Nov. 2, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today reported results for the first quarter of fiscal year 2027, which ended Sept.
Clorox upgraded to In Line from Underperform at Evercore ISI
Evercore ISI analyst Javier Escalante upgraded Clorox (CLX) to In Line from Underperform with a $99 price target ahead of the company reporting after the close. The firm, whose estimates…
The Clorox Company Proxy statement: Proxy filing
The Clorox Company filed a proxy statement on October 29, 2026, providing details for shareholder voting and corporate governance matters.
Clorox Names Unilever's Fabian Garcia as CEO
Clorox has hired Unilever executive Fabian Garcia as its next chief executive. Garcia will step into the role effective Jan. 5, succeeding Linda Rendle who announced in May that she was stepping down ...
Clorox appoints Fabian Garcia as CEO, effective January 5, 2027
The Clorox (CLX) Company announced that its Board of Directors has appointed Fabian Garcia as CEO, effective Jan. 5, 2027, following a comprehensive search. Garcia will succeed Linda Rendle, who…
Clorox Appoints Fabian Garcia as CEO
Matthew Shattock to Resume Position as Independent Chair OAKLAND, Calif., Oct. 29, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that its Board of Directors has appointed Fabian ...
3 of the Best Smaller-Cap Stocks to Own
These stocks of smaller companies with wide economic moats are good long-term buys when you can get them on sale.
Clorox price target lowered to $95 from $98 at Deutsche Bank
Deutsche Bank analyst Steve Powers lowered the firm’s price target on Clorox (CLX) to $95 from $98 and keeps a Hold rating on the shares as part of a fiscal…
Clorox price target lowered to $83 from $95 at JPMorgan
JPMorgan analyst Andrea Teixeira lowered the firm’s price target on Clorox (CLX) to $83 from $95 and keeps an Underweight rating on the shares. The firm adjusted targets in the…
Clorox price target lowered to $80 from $84 at Barclays
Barclays lowered the firm’s price target on Clorox (CLX) to $80 from $84 and keeps an Underweight rating on the shares. The firm adjusted targets in the consumer staples group…
Clorox price target lowered to $91 from $105 at UBS
UBS lowered the firm’s price target on Clorox (CLX) to $91 from $105 and keeps a Neutral rating on the shares.
Clorox price target lowered to $87 from $97 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Clorox (CLX) to $87 from $97 and keeps an Equal Weight rating on the shares.
Clorox Announces November 2 Webcast of First-Quarter Fiscal Year 2027 Results
OAKLAND, Calif., Oct. 12, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its first-quarter fiscal year 2027 results on November 2, 2026.